Aspirin Concept

subject area of

• 'MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics.  Journal Articles
• 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2020 International Consensus on First Aid Science With Treatment Recommendations.  Journal Articles
• A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Journal Articles
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Journal Articles
• A Pulsed Tangential-Flow Ultrafiltration Technique for Studying Protein-Drug Binding  Journal Articles
• A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo  Journal Articles
• A fulminant neurologic presentation of systemic lupus erythematosus  Journal Articles
• A guide to GRADE guidelines for the readers of JTH  Journal Articles
• A hybrid automated event adjudication system for clinical trials  Journal Articles
• A novel treatment adjunct for aspirin exacerbated respiratory disease: the low‐salicylate diet: a multicenter randomized control crossover trial  Journal Articles
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Journal Articles
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)  Journal Articles
• A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract  Journal Articles
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Journal Articles
• A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip  Journal Articles
• A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation  Journal Articles
• A survey evaluating surgeons’ peri-operative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial  Journal Articles
• ANTIPLATELET AGENTS: THEIR ROLE IN THE PREVENTION OF SUDDEN DEATH  Journal Articles
• ASCEND-Eye  Journal Articles
• ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?  Journal Articles
• ASPIRIN INHIBITS PLATELET-FUNCTION INDEPENDENT OF THE ACETYLATION OF CYCLO-OXYGENASE  Journal Articles
• Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy  Journal Articles
• Acetylsalicylic acid (ASA) increases the solubility of cholesterol when incorporated in lipid membranes  Journal Articles
• Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease  Journal Articles
• Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial  Journal Articles
• Acute in vitro effects of ethanol on responses of platelets from cholesterol-fed and Watanabe heritable hyperlipidemic rabbits.  Journal Articles
• Acute stroke management.  Journal Articles
• Adding aspirin to clopidogrel after TIA and ischemic stroke  Journal Articles
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Journal Articles
• Adjunctive therapy for myocardial infarction.  Journal Articles
• Advances in Antithrombotic Therapy  Journal Articles
• Advances in Antithrombotic Therapy: Novel Agents  Journal Articles
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia  Journal Articles
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Journal Articles
• Anticoagulants in acute coronary syndromes  Journal Articles
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Journal Articles
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Journal Articles
• Antiphospholipid antibody syndrome  Journal Articles
• Antiplatelet Agents: Rationale and Results  Journal Articles
• Antiplatelet Drugs  Journal Articles
• Antiplatelet Drugs  Journal Articles
• Antiplatelet Therapy  Journal Articles
• Antiplatelet Therapy in Cerebral Small Vessel Disease  Journal Articles
• Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention  Journal Articles
• Antiplatelet drugs  Journal Articles
• Antiplatelet drugs in thromboembolism  Journal Articles
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Journal Articles
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Journal Articles
• Antithrombotic Agents  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Drugs  Journal Articles
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy for Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy for Coronary Artery Disease  Journal Articles
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Journal Articles
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Journal Articles
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.  Journal Articles
• Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic therapy. Introduction.  Journal Articles
• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation  Journal Articles
• Apixaban in Patients with Atrial Fibrillation  Journal Articles
• Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy  Journal Articles
• Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial.  Journal Articles
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Journal Articles
• Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation  Journal Articles
• Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome  Journal Articles
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Journal Articles
• Appropriate Assessment of the Functional Consequences of Platelet Cyclooxygenase-1 Inhibition by Aspirin in vivo  Journal Articles
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Journal Articles
• Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials  Journal Articles
• Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?  Journal Articles
• Aspirin  Journal Articles
• Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study  Journal Articles
• Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question  Journal Articles
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Journal Articles
• Aspirin and Other Platelet-Active Drugs  Conferences
• Aspirin and Other Platelet-Active Drugs  Journal Articles
• Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial  Journal Articles
• Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.  Journal Articles
• Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure?  Journal Articles
• Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects  Journal Articles
• Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.  Journal Articles
• Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.  Journal Articles
• Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?  Journal Articles
• Aspirin for Dual Prevention of Venous and Arterial Thrombosis  Journal Articles
• Aspirin for Preventing Venous Thromboembolism  Journal Articles
• Aspirin for Prevention and Treatment of Cardiovascular Disease  Journal Articles
• Aspirin for preventing venous thromboembolism.  Journal Articles
• Aspirin for preventing venous thromboembolism.  Journal Articles
• Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis  Journal Articles
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Aspirin for the primary prevention of cardiovascular events  Journal Articles
• Aspirin improves the outcome of intra-arterial thrombolysis with tissue plasminogen activator  Journal Articles
• Aspirin in Patients Undergoing Noncardiac Surgery  Journal Articles
• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery  Journal Articles
• Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial  Journal Articles
• Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke  Journal Articles
• Aspirin in secondary prevention of recurrent venous thromboembolism  Journal Articles
• Aspirin in the prevention of cancer  Journal Articles
• Aspirin in the treatment of cardiovascular disease: A review  Journal Articles
• Aspirin inhibits formation of cholesterol rafts in fluid lipid membranes  Journal Articles
• Aspirin inhibits platelet function independent of the acetylation of ciclo-oxygenase  Journal Articles
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Journal Articles
• Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets  Journal Articles
• Aspirin resistance  Journal Articles
• Aspirin resistance  Journal Articles
• Aspirin resistance and its implications in clinical practice.  Journal Articles
• Aspirin resistance: Table 1  Journal Articles
• Aspirin resistance: does it exist and is it an important clinical problem?  Journal Articles
• Aspirin resistance: position paper of the Working Group on Aspirin Resistance  Journal Articles
• Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.  Journal Articles
• Aspirin response variability after major orthopedic surgery  Journal Articles
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Journal Articles
• Aspirin tolerance and leukotriene biosynthesis in Churg‐Strauss syndrome  Journal Articles
• Aspirin, Sulfinpyrazone, or Both in Unstable Angina  Journal Articles
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events  Journal Articles
• Aspirin: its effect on platelet glycolysis and release of adenosine diphosphate.  Journal Articles
• Assessment of antithrombotic drugs ex vivo and in vivo.  Journal Articles
• Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes  Journal Articles
• Association of cyclooxygenase-2 genetic variant with cardiovascular disease  Journal Articles
• Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study  Journal Articles
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Journal Articles
• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups  Journal Articles
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Journal Articles
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome  Journal Articles
• Benefits and harms of aspirin desensitization for aspirin‐exacerbated respiratory disease: a systematic review and meta‐analysis  Journal Articles
• Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin  Journal Articles
• Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding Risks With Non-Vitamin K Oral Anticoagulants Versus Single Antiplatelet Therapy : A Systematic Review and Meta-analysis of Randomized Trials.  Journal Articles
• Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis  Journal Articles
• Bleeding associated with antithrombotic therapy.  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Canadian Spontaneous Coronary Artery Dissection Cohort Study  Journal Articles
• Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events  Journal Articles
• Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks  Journal Articles
• Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib  Journal Articles
• Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease  Journal Articles
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Journal Articles
• Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.  Journal Articles
• Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): A population-based perspective  Journal Articles
• Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source  Journal Articles
• Characteristics of sudden potential drop in bullfrog gastric mucosa  Journal Articles
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Journal Articles
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins  Journal Articles
• Clinical decisions. Management of stable coronary disease.  Journal Articles
• Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials  Journal Articles
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin  Journal Articles
• Clinical potential of antithrombotic drugs in coronary syndromes  Journal Articles
• Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)  Journal Articles
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Journal Articles
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Journal Articles
• Clopidogrel plus aspirin in atrial fibrillation.  Journal Articles
• Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis  Journal Articles
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Journal Articles
• Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Journal Articles
• Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Journal Articles
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Journal Articles
• Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease.  Conferences
• Combination Therapy to Prevent Cardiovascular Disease  Journal Articles
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Journal Articles
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Journal Articles
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Journal Articles
• Comorbidities associated with eosinophilic chronic rhinosinusitis: A systematic review and meta‐analysis  Journal Articles
• Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations  Journal Articles
• Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis  Journal Articles
• Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit  Journal Articles
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Journal Articles
• Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis  Journal Articles
• Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant  Journal Articles
• Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events  Journal Articles
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Journal Articles
• Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura  Journal Articles
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases  Journal Articles
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Journal Articles
• Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial  Journal Articles
• Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?  Journal Articles
• Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: Direct measurement of percent release of β-thromboglobulin and assessment by flow cytometry of P-selectin expression \textbar Request PDF  Other
• Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin  Journal Articles
• Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.  Journal Articles
• Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose  Journal Articles
• Coronary artery stenting in patients treated by clopidogrel without aspirin  Journal Articles
• Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)  Journal Articles
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Journal Articles
• Critical evaluation of platelet-inhibiting drugs in thrombotic disease.  Journal Articles
• Current Status of Chemoprevention in Barrett’s Esophagus  Journal Articles
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin  Journal Articles
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint  Journal Articles
• Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective  Journal Articles
• Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption.  Journal Articles
• Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.  Journal Articles
• Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy  Journal Articles
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Journal Articles
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Journal Articles
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Journal Articles
• Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments  Journal Articles
• Different perspective on ASA use.  Journal Articles
• Dipyridamole disposition after chronic administration: Effect of aspirin  Journal Articles
• Divergent effects of aspirin and salicylate on glucose and glycogen metabolism in human platelets  Journal Articles
• Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?  Journal Articles
• Does aspirin really reduce the risk of colon cancer?  Journal Articles
• Does long term aspirin prevent cancer?  Journal Articles
• Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis  Journal Articles
• Does the long-term use of aspirin decrease the risk of death due to cancer?  Journal Articles
• Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness  Journal Articles
• Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes  Journal Articles
• Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial  Journal Articles
• Drug Effects on Platelet Adherence to Collagen and Damaged Vessel Walls \textbar Request PDF  Other
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Journal Articles
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Journal Articles
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Journal Articles
• Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society  Journal Articles
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline  Journal Articles
• Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events  Journal Articles
• Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score  Journal Articles
• Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances  Journal Articles
• Dyspepsia and aspirin.  Journal Articles
• ESPRIT trial  Journal Articles
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Journal Articles
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome  Journal Articles
• Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials  Journal Articles
• Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo  Journal Articles
• Effect of Aspirin on Hemostasis and Thrombosis  Journal Articles
• Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease  Journal Articles
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Journal Articles
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Journal Articles
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Journal Articles
• Effect of Drugs on Platelets and Complications of Vascular Disease  Other
• Effect of PCI on Quality of Life in Patients with Stable Coronary Disease  Journal Articles
• Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry  Journal Articles
• Effect of Ramipril on Cardiovascular Events in High-Risk Patients  Journal Articles
• Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial  Journal Articles
• Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study  Journal Articles
• Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.  Journal Articles
• Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2)  Journal Articles
• Effect of calcium concentration and inhibitors on the responses of platelets stimulated with collagen: Contrast between human and rabbit platelets  Journal Articles
• Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists  Journal Articles
• Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease  Journal Articles
• Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent collagen \textbar Request PDF  Other
• Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial  Journal Articles
• Effect of prostaglandin synthesis inhibitors on spontaneous and endotoxin-induced abortion in mice  Journal Articles
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Journal Articles
• Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials  Journal Articles
• Effectiveness of Anticoagulants  Journal Articles
• Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patienis undergoing elective knee surgery  Journal Articles
• Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study  Journal Articles
• Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation  Journal Articles
• Effects of Tris on Responses of Human and Rabbit Platelets to Aggregating Agents  Journal Articles
• Effects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes  Journal Articles
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Journal Articles
• Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study  Journal Articles
• Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease  Journal Articles
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Journal Articles
• Effects of aspirin, naloxone and placebo  Journal Articles
• Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma  Journal Articles
• Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.  Journal Articles
• Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial  Journal Articles
• Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review  Journal Articles
• Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina  Journal Articles
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study  Journal Articles
• Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial  Journal Articles
• Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials  Journal Articles
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Journal Articles
• Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD  Journal Articles
• Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke  Journal Articles
• Efficacy of aspirin for sporadic vestibular schwannoma: a meta-analysis  Journal Articles
• Eicosapentaenoic Acid Interferes with U46619-Stimulated Formation of Inositol Phosphates in Washed Rabbit Platelets  Journal Articles
• Endothelial Cells Produce a Lipoxygenase Derived Chemo-Repellent which Influences Platelet/Endothelial Cell Interactions – Effect of Aspirin and Salicylate  Journal Articles
• Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial  Journal Articles
• Enzyme Activities on the Platelet Surface in Relation to the Action of Adenosine Diphosphate  Other
• Eosinophilic Asthma  Journal Articles
• Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial  Journal Articles
• Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial  Journal Articles
• European and Australian stroke prevention in reversible ischaemia trial (ESPRIT) study group  Journal Articles
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Journal Articles
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Journal Articles
• Evidence-based treatment of the antiphospholipid syndrome  Journal Articles
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Journal Articles
• External applicability of the COMPASS trial: the Western Denmark Heart Registry  Journal Articles
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Journal Articles
• Factors responsible for ADP-induced release reaction of human platelets  Other
• Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy  Journal Articles
• Failure of Aspirin to Prevent Atherothrombosis  Journal Articles
• Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis  Journal Articles
• Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD  Journal Articles
• Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial  Journal Articles
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Journal Articles
• Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale  Journal Articles
• Hacked by the Russians  Journal Articles
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Hemorrhagic Complications of Anticoagulant Therapy  Journal Articles
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Journal Articles
• High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source  Journal Articles
• Hirulog in the Treatment of Unstable Angina  Journal Articles
• How Should Results from Completed Studies Influence Ongoing Clinical Trials?  Journal Articles
• How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?  Journal Articles
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Journal Articles
• How good is aspirin for patients with acute brain ischaemia?  Journal Articles
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction  Journal Articles
• Identifying and Treating Young Patients at Risk for Cardiovascular Events  Journal Articles
• Identifying the highest risk vascular patients: Insights from the XATOA registry  Journal Articles
• Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin  Journal Articles
• Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease  Journal Articles
• Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised Trial  Journal Articles
• Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel  Journal Articles
• Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])  Journal Articles
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry  Journal Articles
• Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial  Journal Articles
• Impacts of metformin and aspirin on life history features and longevity of crickets: trade-offs versus cost-free life extension?  Journal Articles
• In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not  Journal Articles
• In healthy older adults, daily aspirin increased cancer mortality  Journal Articles
• In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y  Journal Articles
• In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding  Journal Articles
• Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trial  Journal Articles
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Journal Articles
• Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid  Journal Articles
• Increased Platelet Destruction  Journal Articles
• Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel  Journal Articles
• Increased dipyridamole plasma concentrations associated with salicylate administration. Relationship to effects on platelet aggregation in vivo  Journal Articles
• Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation  Journal Articles
• Independent predictors of stroke in patients with atrial fibrillation  Journal Articles
• Indirect comparison: relative risk fallacies and odds solution  Journal Articles
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Journal Articles
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention  Journal Articles
• Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women  Journal Articles
• Influence of a critical path management tool in the treatment of acute myocardial infarction. Clinical Quality Improvement Network Investigators.  Journal Articles
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Journal Articles
• Inhibition of COX pathway in experimental myocardial infarction  Journal Articles
• Inhibition of COX pathway in experimental myocardial infarction.  Journal Articles
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Journal Articles
• Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia  Journal Articles
• Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study  Journal Articles
• Injury Of Cultured Endothelial Cells By Thrombin-Stimulated Platelets  Other
• Inositol phospholipid metabolism in human platelets stimulated by ADP  Journal Articles
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Journal Articles
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Journal Articles
• Interaction of Aspirin (Acetylsalicylic Acid) with Lipid Membranes  Journal Articles
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding  Journal Articles
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Journal Articles
• Investigation and management of erythrocytosis  Journal Articles
• Is Daily Low-Dose Aspirin Safe to Take Following Laparoscopic Roux-en-Y Gastric Bypass for Obesity Surgery?  Journal Articles
• Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?  Journal Articles
• Is there a benefit of low-dose aspirin in assisted reproduction?  Journal Articles
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Journal Articles
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Journal Articles
• Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.  Journal Articles
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Journal Articles
• Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply  Journal Articles
• Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin  Journal Articles
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Journal Articles
• Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction  Journal Articles
• Lipoxins and Aspirin-Triggered Lipoxins in Airway Responses  Journal Articles
• Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials  Journal Articles
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Journal Articles
• Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial  Journal Articles
• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction  Journal Articles
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Journal Articles
• Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis  Journal Articles
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Journal Articles
• Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment  Journal Articles
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Journal Articles
• Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD  Journal Articles
• Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.  Journal Articles
• Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture  Journal Articles
• Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials  Journal Articles
• Low-dose Rivaroxaban Plus Aspirin for the Prevention of Cardiovascular Events: an Evaluation of COMPASS  Journal Articles
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial  Journal Articles
• Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.  Journal Articles
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Journal Articles
• Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial  Journal Articles
• Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial  Journal Articles
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Journal Articles
• Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial  Conferences
• Lowering of plasma isoxicam concentrations with acetylsalicylic acid.  Journal Articles
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease  Journal Articles
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Journal Articles
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Journal Articles
• Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management Strategies  Journal Articles
• Mechanism of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187 \textbar Request PDF  Other
• Mechanisms of Aspirin-Intolerant Asthma: Identifying Inflammatory Pathways in the Pathogenesis of Asthma  Journal Articles
• Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity  Journal Articles
• Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source  Journal Articles
• Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions  Journal Articles
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS ₂ and CHA ₂ DS ₂ -VASc Scores in Patients With Atrial Fibrillation  Journal Articles
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation  Journal Articles
• Modification of platelet function  Other
• Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent  Journal Articles
• Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial  Journal Articles
• Mortality Benefit in the Compass Trial: is It Related to Superior Statistical Power Or Better Efficacy and safety?  Journal Articles
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease  Journal Articles
• Mortality Risk and Patterns of Practice in 2,070 Patients With Acute Myocardial Infarction, 1987-92  Journal Articles
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Journal Articles
• Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial  Journal Articles
• Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil  Journal Articles
• Myocardial injury after non-cardiac surgery: diagnosis and management  Journal Articles
• Myocardial injury after noncardiac surgery  Journal Articles
• Myths and facts in the use of anti-inflammatory drugs  Journal Articles
• Nasal polyps, bronchial asthma and aspirin sensitivity.  Journal Articles
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Journal Articles
• Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy  Journal Articles
• Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation  Journal Articles
• New Antithrombotic Drugs: Beyond Aspirin and Heparin  Journal Articles
• New antithrombotic agents—insights from clinical trials  Journal Articles
• Non-variceal upper gastrointestinal bleeding  Journal Articles
• Non‐Steroidal Anti‐Inflammatory Agents and Coronary Heart Disease  Journal Articles
• Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study  Journal Articles
• Once versus twice daily aspirin after coronary bypass surgery: a randomized trial  Journal Articles
• One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial  Journal Articles
• One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery  Journal Articles
• Optimal dose for starting and maintaining low-dose aspirin  Journal Articles
• Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis  Journal Articles
• Oral Anticoagulant Therapy in Patients with Coronary Artery Disease  Journal Articles
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Journal Articles
• Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease  Journal Articles
• Oral anticoagulants in patients with coronary artery disease  Journal Articles
• Oral anticoagulants in patients with coronary artery disease: an inexpensive and effective strategy  Journal Articles
• Oral antiplatelet therapy.  Journal Articles
• Oral factor Xa inhibitors and risk of subdural hematoma  Journal Articles
• Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.  Journal Articles
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Journal Articles
• Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis  Journal Articles
• Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification  Journal Articles
• PLATELET SUPPRESSIVE THERAPY  Journal Articles
• Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro  Journal Articles
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways  Journal Articles
• Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease  Journal Articles
• Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial  Journal Articles
• Part 9: Acute Coronary Syndromes  Journal Articles
• Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes  Other
• Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry  Journal Articles
• Patients with Peripheral Artery Disease in the COMPASS Trial  Journal Articles
• Peptic ulcer disease today  Journal Articles
• Periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Canadian Task Force on the Periodic Health Examination.  Journal Articles
• Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury  Journal Articles
• Perioperative Aspirin for Prevention of Venous Thromboembolism  Journal Articles
• Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Journal Articles
• Perioperative Treatment With Aspirin or Clonidine and Risk of Acute Kidney Injury—Reply  Journal Articles
• Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial  Journal Articles
• Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis  Journal Articles
• Physicians' recommendations for patients who undergo noncardiac surgery.  Journal Articles
• Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future  Journal Articles
• Platelet Interactions with the Endothelium and the Subendothelium: the Role of Thrombin and Prostacyclin  Journal Articles
• Platelet activating factor: Regulation by mast cells and aspirin  Journal Articles
• Platelet inhibitors in the treatment of thrombosis.  Journal Articles
• Platelet tests and antiplatelet drugs in coronary artery disease.  Journal Articles
• Platelet-Active Drugs  Journal Articles
• Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Journal Articles
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Journal Articles
• Platelets and Thrombosis in the Development of Atherosclerosis and Its Complications  Other
• Platelets.  Journal Articles
• Point-of-care Testing for Assessment of Adequacy of Oral Antiplatelet Therapy in Patients With Cardiovascular Disease  Journal Articles
• Polypill for Cardiovascular Disease Prevention—Reply  Journal Articles
• Polypill in Persons without Cardiovascular Disease  Journal Articles
• Polypill with or without Aspirin in Persons without Cardiovascular Disease  Journal Articles
• Polypill: the evidence and the promise  Journal Articles
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Journal Articles
• Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism  Journal Articles
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Journal Articles
• Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial  Journal Articles
• Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial  Journal Articles
• Preeclampsia  Journal Articles
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Journal Articles
• Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.  Journal Articles
• Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement  Journal Articles
• Prevention of Venous Thromboembolism  Journal Articles
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Journal Articles
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Journal Articles
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Journal Articles
• Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness  Journal Articles
• Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)  Journal Articles
• Prevention of pre‐eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence  Journal Articles
• Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double‐blind trial  Journal Articles
• Prevention of thrombosis in antiphospholipid syndrome  Journal Articles
• Prevention of vascular complications after cerebral ischaemia of arterial organ; the ESPRIT study: mild anticoagulant therapy, combination treatment with acetylsalicylic acid and dipyridamole, or treatment with acetylsalicylic acid alone?  Journal Articles
• Primary thrombocythaemia in childhood: Symptomatic episodes and their relationship thromboxane A2, 6-keto-PGE1 and 12-hydroxy-eicosatetraenoic acid production: A case report  Journal Articles
• Principles and practice of coronary thrombolysis and conjunctive treatment  Journal Articles
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Journal Articles
• Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.  Journal Articles
• Proceedings: Failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery.  Journal Articles
• Proceedings: Inhibition of collagen- or thrombin-induced shape change of rabbit platelets  Journal Articles
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.  Journal Articles
• Prophylaxis of Venous Thromboembolism  Journal Articles
• Prophylaxis of venous thromboembolism. An overview.  Journal Articles
• Prostacyclin and thromboxane generating systems in rabbits pretreated with aspirin  Journal Articles
• Prostaglandin I2 (prostacyclin).  Journal Articles
• Prostaglandins and Platelets  Journal Articles
• Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?  Journal Articles
• Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?  Journal Articles
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Journal Articles
• Quantifying Surgical Completeness in Patients with Aspirin Exacerbated Respiratory Disease  Journal Articles
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Journal Articles
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Journal Articles
• Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial  Journal Articles
• Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study  Journal Articles
• Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Journal Articles
• Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs placebo and clonidine vs placebo in patients undergoing noncardiac surgery  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Journal Articles
• Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus  Journal Articles
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Journal Articles
• Reasons for resistance to aspirin in cardiovascular disease.  Journal Articles
• Recent advances in understanding, diagnosing and treating venous thrombosis  Journal Articles
• Recommendations for the Appropriate Use of Anti-Inflammatory Drugs in the Era of the Coxibs: Defining the Role of Gastroprotective Agents  Journal Articles
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation  Journal Articles
• Recurrent spontaneous early pregnancy loss and low dose aspirin.  Journal Articles
• Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD  Journal Articles
• Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study  Journal Articles
• Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin  Journal Articles
• Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin  Journal Articles
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Journal Articles
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Journal Articles
• Reply  Journal Articles
• Reply  Journal Articles
• Reply  Journal Articles
• Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”  Journal Articles
• Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches  Journal Articles
• Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion  Journal Articles
• Reversal of the anti‐platelet effects of aspirin and clopidogrel  Journal Articles
• Review of aspirin and clopidogrel resistance in peripheral arterial disease  Journal Articles
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial  Journal Articles
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Journal Articles
• Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation  Journal Articles
• Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.  Journal Articles
• Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin  Journal Articles
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Journal Articles
• Risk of recurrent venous thromboembolism according to baseline risk factor profiles  Journal Articles
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Journal Articles
• Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis  Journal Articles
• Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD  Journal Articles
• Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial  Journal Articles
• Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial  Journal Articles
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction  Journal Articles
• Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease  Journal Articles
• Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Journal Articles
• Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization  Journal Articles
• Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial  Journal Articles
• Rivaroxaban for Patients with Intermittent Claudication.  Journal Articles
• Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline  Journal Articles
• Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source  Journal Articles
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Journal Articles
• Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits  Journal Articles
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Journal Articles
• Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial  Journal Articles
• Rivaroxaban plus aspirin after lower-extremity revascularization.  Journal Articles
• Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition  Journal Articles
• Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy  Journal Articles
• Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial  Journal Articles
• Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial  Journal Articles
• Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial  Journal Articles
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease  Journal Articles
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion  Journal Articles
• Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease.  Journal Articles
• Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease  Journal Articles
• Role of aspirin for prevention and treatment of perioperative cardiovascular events  Journal Articles
• Role of lipoxygenase metabolism in platelet function: Effect of aspirin and salicylate  Journal Articles
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Journal Articles
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Journal Articles
• Safer anticoagulant therapy after heart valve replacement  Journal Articles
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin  Journal Articles
• Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist  Journal Articles
• Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)  Journal Articles
• Sekundärprävention nach ischämischem zerebralem Insult  Journal Articles
• Selection Bias, Orthopaedic Style  Journal Articles
• Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction  Journal Articles
• Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin  Journal Articles
• Sex differences in the antithrombotic effects of aspirin  Journal Articles
• Sex related differences in platelet function: the effect of aspirin  Journal Articles
• Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation  Journal Articles
• Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD  Journal Articles
• Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention  Journal Articles
• Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration  Journal Articles
• Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?  Journal Articles
• Should NSAID/low‐dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing  Journal Articles
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Journal Articles
• Should we give aspirins and statins to the elderly?  Journal Articles
• Should we give aspirins and statins to the elderly?  Journal Articles
• Signature Celebration of Gastroenterology , Colorectal Cancer  Journal Articles
• Single or Dual Antiplatelet Treatment after TAVI  Journal Articles
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Journal Articles
• State of the Art-A Journey through the World of Antithrombotic Therapy  Journal Articles
• Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.  Journal Articles
• Stroke Outcomes in the COMPASS Trial  Journal Articles
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Journal Articles
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Journal Articles
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Journal Articles
• Stroke prevention in atrial fibrillation: Closing the gap  Journal Articles
• Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial  Journal Articles
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.  Journal Articles
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Journal Articles
• THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY  Journal Articles
• THE RELATIONSHIP BETWEEN DOSE OF ASPIRIN, SIDE-EFFECTS AND ANTITHROMBOTIC EFFECTIVENESS  Journal Articles
• TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease  Journal Articles
• The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal  Journal Articles
• The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase  Journal Articles
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Journal Articles
• The COMPASS Trial  Journal Articles
• The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.  Journal Articles
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease  Journal Articles
• The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective  Journal Articles
• The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis  Journal Articles
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Journal Articles
• The Effect of Thrombin on Platelet Accumulation on the Vessel Wall - Influence of Heparin and Aspirin  Journal Articles
• The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey  Journal Articles
• The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population  Journal Articles
• The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women  Journal Articles
• The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences  Journal Articles
• The Influence of Red Blood Cells on the Effects of Aspirin or Sulphinpyrazone on Platelet Adherence to Damaged Rabbit Aorta  Journal Articles
• The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis  Journal Articles
• The Molecular Structure of Human Red Blood Cell Membranes from Highly Oriented, Solid Supported Multi-Lamellar Membranes  Journal Articles
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Journal Articles
• The Perioperative Management of Antithrombotic Therapy  Journal Articles
• The Primary and Secondary Prevention of Coronary Artery Disease  Journal Articles
• The Secondary Prevention of Small Subcortical Strokes (SPS3) Study  Journal Articles
• The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin  Journal Articles
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Journal Articles
• The aspirin controversy in primary prevention  Journal Articles
• The beginning of the end of warfarin?  Journal Articles
• The cost implications of a polypill for primary prevention in the TIPS-3 trial  Journal Articles
• The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial  Journal Articles
• The diagnosis and prevention of post operative venous thrombosis.  Journal Articles
• The effect of acetylsalicylic acid and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit  Journal Articles
• The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis  Journal Articles
• The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae  Journal Articles
• The effect of aspirin on the size of the hemostatic plug  Journal Articles
• The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies  Journal Articles
• The kinetics of elimination of salicylic acid and the formation of gentisic acid  Journal Articles
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Journal Articles
• The optimal antithrombotic dose of aspirin  Journal Articles
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Journal Articles
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Journal Articles
• The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trial  Journal Articles
• The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study  Journal Articles
• The reemergence of aspirin for the prevention of venous thromboembolism.  Journal Articles
• The role of platelets and platelet inhibition in acute myocardial infarction  Journal Articles
• The safety of antithrombotic therapy during pregnancy  Journal Articles
• The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects  Journal Articles
• Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.  Journal Articles
• There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy  Journal Articles
• Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemia.  Journal Articles
• Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials  Journal Articles
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Journal Articles
• Thrombogenic Effect of High-Dose Aspirin in Rabbits  Journal Articles
• Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction  Conferences
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin  Journal Articles
• Thrombosis and embolism in pediatric cardiomyopathy  Journal Articles
• Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study  Journal Articles
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial  Journal Articles
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Journal Articles
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Journal Articles
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Journal Articles
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Journal Articles
• Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial  Journal Articles
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Which form of aspirin is the fastest to inhibit platelet aggregation in emergency department patients with non-ST segment elevation myocardial infarction?  Journal Articles
• Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial  Journal Articles
• Treatment of Acute Coronary Syndromes  Journal Articles
• Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study  Journal Articles
• Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting  Journal Articles
• Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018  Journal Articles
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Journal Articles
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction  Journal Articles
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Journal Articles
• Unstable angina.  Journal Articles
• Unstable angina.  Journal Articles
• Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease  Journal Articles
• Upper gastrointestinal haemorrhage following cardiac surgery  Journal Articles
• Urinary thromboxane and risk of cardiovascular events: role of aspirin  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4)  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Using aspirin to prevent cognitive decline  Journal Articles
• Uso de aspirina como profilaxis secundaria en pacientes sin stents coronarios sometidos a cirugía no-cardiaca y cirugía no-endarterectomía carotídea  Journal Articles
• Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin  Journal Articles
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Journal Articles
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Journal Articles
• Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms  Journal Articles
• Vascular access and antiplatelet therapies: does one influence the other?  Journal Articles
• Vascular viewpoint  Journal Articles
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Journal Articles
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Vessel injury, platelet adherence, and platelet survival.  Journal Articles
• Vocal cord paralysis secondary to spontaneous internal carotid dissection: Case report and systematic review of the literature  Journal Articles
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Journal Articles
• Warfarin and Aspirin after Heart-Valve Replacement  Journal Articles
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Journal Articles
• Warfarin in Heart Failure  Journal Articles
• When guidelines collide  Journal Articles
• Will prasugrel supersede clopidogrel for acute coronary syndromes?  Journal Articles
• Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both  Journal Articles
• [Antithrombotic treatment of atrial fibrillation].  Journal Articles
• [Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome].  Journal Articles
• [Prevention of deep vein thrombosis and pulmonary thromboembolism].  Journal Articles
• [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].  Journal Articles
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Journal Articles